Stock ACTIVEFINE ACTIVE FINE CHEMICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Active Fine Chemicals Limited

Equities

ACTIVEFINE

BD0483ACFCH9

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
12.2 BDT -2.40% Intraday chart for Active Fine Chemicals Limited -15.28% -36.79%
2022 Active Fine Chemicals Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
2022 Active Fine Chemicals Limited Has Recommends Cash Dividend for the Year Ended on June 30, 2022 CI

Valuation

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Capitalization 1 8,110 5,758 6,574 2,951 4,391 5,159
Enterprise Value (EV) 1 8,157 6,309 7,717 4,966 7,129 7,773
P/E ratio 14.6 x 6.98 x 9.23 x -52.7 x 115 x 199 x
Yield - - 0.73% - 0.27% 0.12%
Capitalization / Revenue 3.81 x 2.67 x 2.72 x 2.26 x 2.41 x 3.09 x
EV / Revenue 3.83 x 2.93 x 3.19 x 3.8 x 3.91 x 4.65 x
EV / EBITDA 7.13 x 5.18 x 5.1 x 5.47 x 7.01 x 7.36 x
EV / FCF -28.5 x -6.83 x -11.3 x -6.22 x -7.84 x 16,232 x
FCF Yield -3.51% -14.6% -8.86% -16.1% -12.8% 0.01%
Price to Book 2.07 x 1.22 x 1.23 x 0.56 x 0.83 x 0.97 x
Nbr of stocks (in thousands) 239,937 239,937 239,937 239,937 239,937 239,937
Reference price 2 33.80 24.00 27.40 12.30 18.30 21.50
Announcement Date 11/23/17 11/8/18 4/3/21 4/3/21 12/2/21 12/15/22
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net sales 1 2,129 2,156 2,419 1,308 1,821 1,672
EBITDA 1 1,144 1,217 1,514 907.5 1,018 1,056
EBIT 1 825.3 772.1 907.8 148 113.3 108.8
Operating Margin 38.77% 35.82% 37.53% 11.32% 6.22% 6.51%
Earnings before Tax (EBT) 1 737.6 641.7 712.7 -55.16 57.76 48.59
Net income 1 553.9 825.4 711.9 -56 38.28 25.91
Net margin 26.02% 38.29% 29.43% -4.28% 2.1% 1.55%
EPS 2 2.308 3.440 2.967 -0.2334 0.1595 0.1080
Free Cash Flow 1 -286 -924.3 -683.7 -797.9 -909 0.4789
FCF margin -13.43% -42.88% -28.26% -61% -49.91% 0.03%
FCF Conversion (EBITDA) - - - - - 0.05%
FCF Conversion (Net income) - - - - - 1.85%
Dividend per Share - - 0.2000 - 0.0500 0.0250
Announcement Date 11/23/17 11/8/18 4/3/21 4/3/21 12/2/21 12/15/22
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net Debt 1 47.5 551 1,143 2,014 2,738 2,615
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.0416 x 0.4527 x 0.7547 x 2.22 x 2.691 x 2.475 x
Free Cash Flow 1 -286 -924 -684 -798 -909 0.48
ROE (net income / shareholders' equity) 14.9% 19.1% 14.1% -1.06% 0.73% 0.49%
ROA (Net income/ Total Assets) 10% 7.96% 8.04% 1.18% 0.84% 0.76%
Assets 1 5,541 10,369 8,849 -4,728 4,551 3,396
Book Value Per Share 2 16.30 19.70 22.30 21.80 22.00 22.10
Cash Flow per Share 2 3.250 3.570 2.010 0.9100 0.7900 2.400
Capex 1 1,042 1,239 1,476 1,426 578 209
Capex / Sales 48.96% 57.46% 61% 109.01% 31.75% 12.48%
Announcement Date 11/23/17 11/8/18 4/3/21 4/3/21 12/2/21 12/15/22
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ACTIVE FINE CHEMICALS LIMITED Stock Active Fine Chemicals Limited
-36.79% 26.66M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ACTIVEFINE Stock
  4. Financials Active Fine Chemicals Limited